Wells Fargo’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Wells Fargo’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.4K	Buy	+12,000	New	+$20K	﹤0.01%	5793

Other funds holding DRTSW

FFM

Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Wells Fargo's DRTSW Position: Q2 2026 in Review

Wells Fargo opened a new position in Alpha Tau Medical Warrant (DRTSW) in Q2 2026: 12,000 shares worth $35.4K. The stake represents ﹤0.01% of the portfolio and ranks #5793 among its holdings.

21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

Wells Fargo held 12,000 shares of Alpha Tau Medical Warrant worth $35.4K as of Q2 2026.
Alpha Tau Medical Warrant was a new Wells Fargo position in Q2 2026.
Alpha Tau Medical Warrant made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5793 holding.
21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.